Predictors of early immunologic response among highly active anti-retroviral therapy naïve patients in Akwa Ibom State

Introduction: CD4 count is a reliable prognostic indicator of immune response to anti retroviral therapy. This study seeks to determine the proportion of HAART naive patients that achieved an early immunologic response at six months of commencing HAART and to predict factors of early immunological...

Full description

Bibliographic Details
Main Authors: Ekanem AM, Udofia EA, Ekrikpo UE, Opara D, Johnson O, Ndifon W, Onajole A
Format: Article
Language:English
Published: Nigerian Medical Association, Akwa Ibom State Branch 2021-10-01
Series:Ibom Medical Journal
Subjects:
Online Access:https://ibommedicaljournal.org/index.php/imjhome/article/view/38
_version_ 1797271905657421824
author Ekanem AM
Udofia EA
Ekrikpo UE
Opara D
Johnson O
Ndifon W
Onajole A
author_facet Ekanem AM
Udofia EA
Ekrikpo UE
Opara D
Johnson O
Ndifon W
Onajole A
author_sort Ekanem AM
collection DOAJ
description Introduction: CD4 count is a reliable prognostic indicator of immune response to anti retroviral therapy. This study seeks to determine the proportion of HAART naive patients that achieved an early immunologic response at six months of commencing HAART and to predict factors of early immunological response to HAART. Materials and Methods: This was an observational longitudinal study among 287 consecutively recruited HAART naive patients in 11 HIV treatment centres of Akwa Ibom using a semi-structured interviewer administered questionnaire for data collection. Data analysis was done using Stata statistical software at a level of significance of P<0.05. Results: About 75% respondents achieved an early immune response. Multivariate analysis revealed that being female (OR 2.47, P=0.001) predicted achievement of early immunological response while being civil servants/professionals (OR 0.44, P =0.02), unemployed (OR 0.34, P= 0.04) and every 10 cell increase in CD4 cell count at baseline (OR 0.94, P=0.001) predicted non achievement of early immunological response. Conclusion: The majority of HAART naïve patients commenced on anti-retroviral therapy achieved an early immunological response at 6 months on ART. Operating flexible HIV services that covers morning, afternoon, evening and weekend services and male friendly HIV services may improve civil servants and males’ utilization of HIV care and support services. Job creation for the unemployed is also recommended.
first_indexed 2024-03-07T14:16:53Z
format Article
id doaj.art-d17346fbbb7d4c39844217eb8c8e7df4
institution Directory Open Access Journal
issn 1597-7188
2735-9964
language English
last_indexed 2024-03-07T14:16:53Z
publishDate 2021-10-01
publisher Nigerian Medical Association, Akwa Ibom State Branch
record_format Article
series Ibom Medical Journal
spelling doaj.art-d17346fbbb7d4c39844217eb8c8e7df42024-03-06T12:03:13ZengNigerian Medical Association, Akwa Ibom State BranchIbom Medical Journal1597-71882735-99642021-10-0114410.61386/imj.v14i4.38Predictors of early immunologic response among highly active anti-retroviral therapy naïve patients in Akwa Ibom StateEkanem AM0Udofia EAEkrikpo UEOpara DJohnson ONdifon WOnajole ADepartment of Community Health, University of Uyo, Uyo, Akwa Ibom State, Nigeria Introduction: CD4 count is a reliable prognostic indicator of immune response to anti retroviral therapy. This study seeks to determine the proportion of HAART naive patients that achieved an early immunologic response at six months of commencing HAART and to predict factors of early immunological response to HAART. Materials and Methods: This was an observational longitudinal study among 287 consecutively recruited HAART naive patients in 11 HIV treatment centres of Akwa Ibom using a semi-structured interviewer administered questionnaire for data collection. Data analysis was done using Stata statistical software at a level of significance of P<0.05. Results: About 75% respondents achieved an early immune response. Multivariate analysis revealed that being female (OR 2.47, P=0.001) predicted achievement of early immunological response while being civil servants/professionals (OR 0.44, P =0.02), unemployed (OR 0.34, P= 0.04) and every 10 cell increase in CD4 cell count at baseline (OR 0.94, P=0.001) predicted non achievement of early immunological response. Conclusion: The majority of HAART naïve patients commenced on anti-retroviral therapy achieved an early immunological response at 6 months on ART. Operating flexible HIV services that covers morning, afternoon, evening and weekend services and male friendly HIV services may improve civil servants and males’ utilization of HIV care and support services. Job creation for the unemployed is also recommended. https://ibommedicaljournal.org/index.php/imjhome/article/view/38Early Immune ResponseHAART NaïveAkwa Ibom
spellingShingle Ekanem AM
Udofia EA
Ekrikpo UE
Opara D
Johnson O
Ndifon W
Onajole A
Predictors of early immunologic response among highly active anti-retroviral therapy naïve patients in Akwa Ibom State
Ibom Medical Journal
Early Immune Response
HAART Naïve
Akwa Ibom
title Predictors of early immunologic response among highly active anti-retroviral therapy naïve patients in Akwa Ibom State
title_full Predictors of early immunologic response among highly active anti-retroviral therapy naïve patients in Akwa Ibom State
title_fullStr Predictors of early immunologic response among highly active anti-retroviral therapy naïve patients in Akwa Ibom State
title_full_unstemmed Predictors of early immunologic response among highly active anti-retroviral therapy naïve patients in Akwa Ibom State
title_short Predictors of early immunologic response among highly active anti-retroviral therapy naïve patients in Akwa Ibom State
title_sort predictors of early immunologic response among highly active anti retroviral therapy naive patients in akwa ibom state
topic Early Immune Response
HAART Naïve
Akwa Ibom
url https://ibommedicaljournal.org/index.php/imjhome/article/view/38
work_keys_str_mv AT ekanemam predictorsofearlyimmunologicresponseamonghighlyactiveantiretroviraltherapynaivepatientsinakwaibomstate
AT udofiaea predictorsofearlyimmunologicresponseamonghighlyactiveantiretroviraltherapynaivepatientsinakwaibomstate
AT ekrikpoue predictorsofearlyimmunologicresponseamonghighlyactiveantiretroviraltherapynaivepatientsinakwaibomstate
AT oparad predictorsofearlyimmunologicresponseamonghighlyactiveantiretroviraltherapynaivepatientsinakwaibomstate
AT johnsono predictorsofearlyimmunologicresponseamonghighlyactiveantiretroviraltherapynaivepatientsinakwaibomstate
AT ndifonw predictorsofearlyimmunologicresponseamonghighlyactiveantiretroviraltherapynaivepatientsinakwaibomstate
AT onajolea predictorsofearlyimmunologicresponseamonghighlyactiveantiretroviraltherapynaivepatientsinakwaibomstate